These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26670245)

  • 1. Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines.
    Ng Q; He F; Kwang J
    Viruses; 2015 Dec; 7(12):6441-57. PubMed ID: 26670245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
    Klein MH
    Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).
    Mao QY; Wang Y; Bian L; Xu M; Liang Z
    Expert Rev Vaccines; 2016 May; 15(5):599-606. PubMed ID: 26732723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of enterovirus 71 vaccines.
    Chong P; Liu CC; Chow YH; Chou AH; Klein M
    Clin Infect Dis; 2015 Mar; 60(5):797-803. PubMed ID: 25352588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.
    Liu CC; Chow YH; Chong P; Klein M
    Vaccine; 2014 Oct; 32(47):6177-82. PubMed ID: 25218294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An overview of the evolution of EV71 vaccine].
    Li M; Yin Y; Li J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):933-6. PubMed ID: 20842875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterovirus 71 vaccine: close but still far.
    Zhang D; Lu J; Lu J
    Int J Infect Dis; 2010 Sep; 14(9):e739-43. PubMed ID: 20400350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the enterovirus 71 VP1 protein as a vaccine candidate.
    Zhou SL; Ying XL; Han X; Sun XX; Jin Q; Yang F
    J Med Virol; 2015 Feb; 87(2):256-62. PubMed ID: 25043151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EV71: an emerging infectious disease vaccine target in the Far East?
    Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
    Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China.
    Li T; Wang H; Lu Y; Li Q; Chen C; Wang D; Li M; Li Y; Lu J; Chen Z; Ma Y; Liu W; Ma M; Wu D; Lu J; Yang Z
    Vaccine; 2018 Jun; 36(26):3772-3778. PubMed ID: 29776754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A safety study of inactivated Enterovirus 71 vaccine.
    Zhou XB; Lu JJ; Jiang YS; Huo Y; Wang JF; Zhou KF; Li B
    Hum Vaccin Immunother; 2013 Jul; 9(7):1430-7. PubMed ID: 23571172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
    Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drug discovery for the treatment of enterovirus 71 infections.
    Shang L; Xu M; Yin Z
    Antiviral Res; 2013 Feb; 97(2):183-94. PubMed ID: 23261847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children.
    Zhang Y; Wang L; Liao Y; Liu L; Ma K; Yang E; Wang J; Che Y; Jiang L; Pu J; Guo L; Feng M; Liang Y; Cui W; Yang H; Li Q
    Vaccine; 2015 Nov; 33(46):6290-7. PubMed ID: 26419198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.
    Zhu F; Xu W; Xia J; Liang Z; Liu Y; Zhang X; Tan X; Wang L; Mao Q; Wu J; Hu Y; Ji T; Song L; Liang Q; Zhang B; Gao Q; Li J; Wang S; Hu Y; Gu S; Zhang J; Yao G; Gu J; Wang X; Zhou Y; Chen C; Zhang M; Cao M; Wang J; Wang H; Wang N
    N Engl J Med; 2014 Feb; 370(9):818-28. PubMed ID: 24571754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.